Paclitaxel-induced hepatic steatosis in patients with breast cancer
dc.contributor.author | Inci, Fatih | |
dc.contributor.author | Karatas, Fatih | |
dc.date.accessioned | 2024-09-29T16:11:40Z | |
dc.date.available | 2024-09-29T16:11:40Z | |
dc.date.issued | 2019 | |
dc.department | Karabük Üniversitesi | en_US |
dc.description.abstract | Purpose: Paclitaxel has been associated with serum aminotransferase elevations, however, paclitaxel induced hepatosteatosis has not been evaluated systematically. This study assessed the rate of paclitaxel-related hepatosteatosis. Methods: Forty one early breast cancer (BC) patients were included the study. Hepatic ultrasonograpy, demographic features and biochemical liver function tests before and after 12 weeks of paclitaxel were assessed. Results: New-onset hepatosteatosis was developed in 26.7% of the patients. Baseline triglyceride>200mg/dL (OR, 11.25; p=0.015), LDH at baseline > 191.48 IU/L (OR, 4.93; p=0.048), and total bilirubin >0.51 mg/dL after paditaxel (OR, 6.17; p=0.042) were found as independent prognostic markers for new-onset hepatosteatosis. Conclusion: Paclitaxel may induce hepatosteatosis in patients with BC. | en_US |
dc.identifier.endpage | 2360 | en_US |
dc.identifier.issn | 1107-0625 | |
dc.identifier.issn | 2241-6293 | |
dc.identifier.issue | 6 | en_US |
dc.identifier.pmid | 31983106 | en_US |
dc.identifier.startpage | 2355 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.14619/8621 | |
dc.identifier.volume | 24 | en_US |
dc.identifier.wos | WOS:000503405400022 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Imprimatur Publications | en_US |
dc.relation.ispartof | Journal of Buon | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | paclitaxel | en_US |
dc.subject | hepatosteatosis | en_US |
dc.subject | breast cancer | en_US |
dc.title | Paclitaxel-induced hepatic steatosis in patients with breast cancer | en_US |
dc.type | Article | en_US |